Why the study?
It was unknown whether myocardial energetics could distinguish obesity cardiomyopathy as a distinct entity from dilated cardiomyopathy.
Does obesity modify the energetic phenotype of dilated cardiomyopathy, and does dietary weight loss improve myocardial contractility and metabolic efficiency in obese DCM patients?
Does obesity modify the energetic phenotype of dilated cardiomyopathy, and does dietary weight loss improve myocardial contractility and metabolic efficiency in obese DCM patients?
Obesity cardiomyopathy exhibits a distinct energetic phenotype from normal-weight dilated cardiomyopathy, characterized by higher ATP demand through creatine kinase, which is partially reversible with dietary weight loss.
Answers are grounded in this paper and cite their sources.
May support weight loss to improve LV function in obese cardiomyopathy; hypothesis-generating for distinct energetics, needing larger trials.
AIMS: We sought to determine if myocardial energetics could distinguish obesity cardiomyopathy as a distinct entity from dilated cardiomyopathy. METHODS AND RESULTS: Sixteen normal weight participants with dilated cardiomyopathy (DCMNW), and 27 with DCM and obesity (DCMOB), were compared to 26 normal weight controls (CTLNW). All underwent cardiac magnetic resonance imaging and 31P spectroscopy to assess function and energetics. Nineteen DCMOB underwent repeat assessment after a dietary weight loss intervention. Adenosine triphosphate (ATP) delivery through creatine kinase (CK flux) was 55% lower in DCMNW than in CTLNW (P = 0.004), correlating with left ventricular ejection fraction (LVEF, r = 0.4, P = 0.015). In contrast, despite similar LVEF (DCMOB 41 ± 7%, DCMNW 38 ± 6%, P = 0.14), CK flux was two-fold higher in DCMOB (P < 0.001), due to higher rate through CK [median kf 0.21 (0.14) vs. 0.11 (0.12) s-1, P = 0.002]. During increased workload, the CTLNW heart increased CK flux by 97% (P < 0.001). In contrast, CK flux was unchanged in DCMNW and fell in DCMOB (by >50%, P < 0.001). Intentional weight loss was associated with positive left ventricular remodelling, with reduced left ventricular end-diastolic volume (by 8%, P < 0.001) and a change in LVEF (40 ± 9% vs. 45 ± 10%, P = 0.002). This occurred alongside a fall in ATP delivery rate with weight loss (by 7%, P = 0.049). CONCLUSIONS: In normal weight, DCM is associated with reduced resting ATP delivery. In obese DCM, ATP demand through CK is greater, suggesting reduced efficiency of energy utilization. Dietary weight loss is associated with significant improvement in myocardial contractility, and a fall in ATP delivery, suggesting improved metabolic efficiency. This highlights distinct energetic pathways in obesity cardiomyopathy, which are both different from dilated cardiomyopathy, and may be reversible with weight loss.
No takes yet. Share an insight, caveat, or question.
Rayner et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: